bendamustine hydrochloride has been researched along with Hyperpigmentation in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Al-Rohil, RN; Kheterpal, MK; Leckey, BD; Selim, MA | 1 |
1 other study(ies) available for bendamustine hydrochloride and Hyperpigmentation
| Article | Year |
|---|---|
Cutaneous involvement by T-cell prolymphocytic leukemia presenting as livedoid vasculopathy.
Topics: Aged; Alemtuzumab; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Immunological; Bendamustine Hydrochloride; Biopsy; Diagnosis, Differential; Disease Progression; Exanthema; Extremities; Fatal Outcome; Humans; Hyperpigmentation; Immunohistochemistry; Leukemia, Prolymphocytic, T-Cell; Male; Skin Neoplasms; Torso; Vascular Diseases | 2021 |